Bálint Hegymegi-Barakonyi

A novel drug discovery concept for tuberculosis: Inhibition of bacterial and host cell signalling

Rita Székely, Frigyes Wáczek, István Szabadkai et al. · Immunology Letters · 2008 · 75 citations · Full text

Pulmonary Tuberculosis, Drug Target, Health Sciences +13

Signal Transduction Therapy with Rationally Designed Kinase Inhibitors

Gÿorgý Kéri, László Őrfi, Dániel Erös et al. · Current Signal Transduction Therapy · 2006 · 48 citations

Drug Target, Pharmacotherapy, Chemical Biology +24

Improved, High Yield Synthesis of 3H-Quinazolin-4-ones, the Key Intermediates of Recently Developed Drugs

László Őrfi, Frigyes Wáczek, János Pató et al. · Current Medicinal Chemistry · 2004 · 39 citations

High Yield Synthesis, Organic Chemistry, Pharmacotherapy +20

Signalling Inhibitors Against Mycobacterium tuberculosis – Early Days of a New Therapeutic Concept in Tuberculosis

Bálint Hegymegi-Barakonyi, Rita Székely, Zoltán V. Varga et al. · Current Medicinal Chemistry · 2008 · 35 citations

Synthesis of selective SRPK-1 inhibitors: Novel tricyclic quinoxaline derivatives

Zsolt Székelyhidi, János Pató, Frigyes Wáczek et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 30 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Heterocyclic +6